Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
boston blog main
boston top stories
glaxosmithkline
3
×
life sciences
national blog main
national top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
crispr
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
ipo
medical devices
national
new york blog main
new york top stories
parkinson's disease
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
sanofi
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
2025
abbvie
acceleron pharma
acid sphingomyelinase deficiency
What
therapeutics
3
×
bio
new
roundup
years
address
adds
ago
allogene
allosteric
black
cancer
clinic
companies
continue
crispr
debut
diamond
diamond’s
disease
diversity
elusive
hot
hotspot
immunotherapy
indication
investors
ipo
juno
leading
life
mammoth
march
medicines
million
molecules
moves
nearly
ohana’s
path
Language
unset
Current search:
glaxosmithkline
×
therapeutics
×
biotech
×
@xconomy.com
3 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More